atopic eczema: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
387 |
4. Check minimum number of eventsNone |
387 |
5. Include endpointsNone |
387 |
6. Filter based on genotype QC (FinnGen only) |
387 |
Control definitions (FinnGen only)
- Control exclude
- L12_DERMATITISECZEMA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L20-L30
- Name in latin
- Erythrodermia universalis NAS
Similar endpoints
↥List of similar endpoints to
Exfoliative dermatitis
based on the number of shared cases.
Similar with more cases:
- Dermatitis and eczema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3058 | 1077 | 1960 |
| Only index persons | 2575 | 944 | 1631 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.03 | 0.05 |
| Only index persons | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 61.96 | 61.58 | 62.08 |
| Only index persons | 60.41 | 60.15 | 60.56 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 387 | 114 | 273 |
| Unadjusted period prevalence (%) | 0.10 | 0.04 | 0.12 |
| Median age at first event (years) | 61.76 | 56.30 | 64.04 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 353
- Matched controls
- 3531
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L26
ICD-10 Finland
Exfoliative dermatitis
+∞
323.0
306
*
D07AB08
ATC
desonide; topical
40.6
162.4
215
130
E000001
ATC
NA
25.0
147.4
248
304
134
Kela drug reimbursment
General erythroderma
1968.8
140.5
127
*
L20.0
ICD-10 Finland
Besnier prurigo
+∞
139.0
124
*
D07AC01
ATC
betamethasone; topical
22.1
135.8
293
637
E0000UV
ATC
NA
20.6
128.5
296
710
D07AA02
ATC
hydrocortisone; topical
20.3
114.0
190
191
D07AB02
ATC
hydrocortisone butyrate; topical
13.4
103.7
240
483
E000003
ATC
NA
43.2
97.2
121
42
L30.9
ICD-10 Finland
Dermatitis, unspecified
17.8
96.6
166
167
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
20.2
95.6
154
130
D07AC13
ATC
mometasone; topical
10.3
85.7
229
536
E000002
ATC
NA
17.2
84.1
144
136
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
+∞
82.6
76
*
D05BB02
ATC
acitretin; oral
56.1
75.9
89
21
D02AE01
ATC
carbamide; topical
24.1
74.5
109
64
TQW80
NOMESCO Finland
Local dermatologic skincare
68.4
74.1
84
16
H02AB06
ATC
prednisolone; systemic
9.0
72.6
282
1081
D07XC01
ATC
betamethasone, combinations; topical
11.3
69.0
147
210
E000006
ATC
NA
23.1
68.3
101
60
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
11.7
63.7
130
167
D11AH01
ATC
tacrolimus; topical
+∞
60.1
56
*
D02AX
ATC
Other emollients and protectives
49.0
59.0
71
18
D07BA04
ATC
hydrocortisone and antiseptics; topical
12.1
55.1
108
124
L30.3
ICD-10 Finland
Infective dermatitis
66.6
53.6
61
11
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
11.1
51.4
105
129
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
105.9
50.4
54
6
L40.0
ICD-10 Finland
Psoriasis vulgaris
18.2
49.0
78
54
D07AD01
ATC
clobetasol; topical
8.1
48.4
123
218
L04AD01
ATC
ciclosporin; systemic
31.2
45.1
60
23
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
+∞
43.6
41
*
XQ802
NOMESCO Finland
Epicutan test
70.7
43.5
49
8
N05BB01
ATC
hydroxyzine; systemic
14.3
42.2
74
64
R06AE07
ATC
cetirizine; oral
4.7
40.3
212
861
D11AX14
ATC
[U] tacrolimus; topical
+∞
37.1
35
*
D09AB01
ATC
zinc bandage without supplements; topical
50.0
36.9
44
10
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
10.2
34.3
71
85
E000007
ATC
NA
12.5
32.5
60
57
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
30.7
29
*
D11AH02
ATC
pimecrolimus; topical
+∞
28.5
27
*
L04AA01
ATC
[U] ciclosporin; systemic
28.2
28.1
38
15
R06AE09
ATC
levocetirizine; oral
5.3
24.7
83
194
L20
ICD-10 Finland
Atopic dermatitis
+∞
24.2
23
*
D07BC01
ATC
betamethasone and antiseptics; topical
5.3
23.2
76
172
R06AX27
ATC
desloratadine; oral
3.7
22.6
121
437
D05AX52
ATC
calcipotriol, combinations; topical
7.2
22.6
57
92
D07CC01
ATC
betamethasone and antibiotics; topical
5.0
22.4
78
188
D05AX02
ATC
calcipotriol; topical
9.6
21.6
45
53
L40.8
ICD-10 Finland
Other psoriasis
36.4
21.4
27
8
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
+∞
21.0
20
*
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
77.7
19.9
22
*
L30.8
ICD-10 Finland
Other specified dermatitis
27.9
19.4
26
10
L30.0
ICD-10 Finland
Nummular dermatitis
12.4
17.9
32
28
395
Kela drug reimbursment
Dupilumab
+∞
17.9
17
*
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
52.8
17.2
20
*
J01DB01
ATC
cefalexin; oral
3.2
17.0
296
2191
XQ800
NOMESCO Finland
Prick test
6.8
16.9
43
70
A46
ICD-10 Finland
Erysipelas
3.6
16.5
84
284
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
31.7
16.3
21
7
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
3.1
16.2
106
430
D07AC14
ATC
methylprednisolone aceponate; topical
8.2
16.1
36
48
D11AH05
ATC
dupilumab; topical
+∞
15.7
15
*
L40.9
ICD-10 Finland
Psoriasis, unspecified
21.2
15.3
22
11
E000004
ATC
NA
12.1
15.0
27
24
H02AB07
ATC
prednisone; oral
3.5
15.0
76
254
D05AX03
ATC
calcitriol; topical
19.4
14.9
22
12
RS340
NOMESCO Finland
NA
83.6
14.7
16
*
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
+∞
14.7
14
*
L44.0
ICD-10 Finland
Pityriasis rubra pilaris
+∞
14.7
14
*
D11AX15
ATC
[U] pimecrolimus; topical
+∞
14.7
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
14.2
178
1039
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
145.3
13.5
14
*
Z2446
NOMESCO Finland
Social worker
4.9
13.5
45
102
S87
ICPC
Dermatitis/atopic eczema
17.6
13.1
20
12
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
12.6
69
242
L29.9
ICD-10 Finland
Pruritus, unspecified
21.0
12.6
18
9
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
7.6
12.6
29
41
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
+∞
12.6
12
*
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
+∞
12.6
12
*
L28.1
ICD-10 Finland
Prurigo nodularis
134.5
12.5
13
*
R06AX22
ATC
ebastine; oral
3.0
11.5
72
277
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
+∞
11.5
11
*
C84.1
ICD-10 Finland
Sézary disease
+∞
11.5
11
*
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
7.0
11.5
28
43
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
123.8
11.5
12
*
H02AB04
ATC
methylprednisolone; systemic
3.1
11.4
68
254
L53.9
ICD-10 Finland
Erythematous condition, unspecified
26.0
11.2
15
6
H02AB09
ATC
hydrocortisone; systemic
9.7
11.2
22
24
L04AX01
ATC
azathioprine; systemic
6.2
11.0
29
50
RS221
NOMESCO Finland
NA
11.7
10.7
19
17
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.8
10.7
46
134
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
8.1
10.6
23
30
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
113.2
10.5
11
*
L27.2
ICD-10 Finland
Dermatitis due to ingested food
+∞
10.5
10
*
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
+∞
10.5
10
*
L20.8
ICD-10 Finland
Other atopic dermatitis
+∞
10.5
10
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
10.0
10.4
20
21
J01FF01
ATC
clindamycin; systemic
2.4
10.4
109
562
RS121
NOMESCO Finland
NA
24.2
10.3
14
6
L50.0
ICD-10 Finland
Allergic urticaria
10.0
9.9
19
20
RJ411
NOMESCO Finland
NA
26.9
9.9
13
5
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.8
9.6
41
119
C03CA01
ATC
furosemide; systemic
2.2
9.5
124
701
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
3.3
9.2
46
151
L28.0
ICD-10 Finland
Lichen simplex chronicus
37.7
9.1
11
*
RJ420
NOMESCO Finland
NA
24.7
9.0
12
5
L40.5
ICD-10 Finland
Arthropathic psoriasis
8.6
8.7
18
22
C10AB05
ATC
fenofibrate; oral
9.3
8.6
17
19
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.0
8.6
27
58
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
20.6
8.5
12
6
J01DA01
ATC
[U] cefalexin; systemic
2.0
8.5
218
1598
RS311
NOMESCO Finland
NA
+∞
8.4
8
*
D11AH04
ATC
alitretinoin; oral
+∞
8.4
8
*
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
+∞
8.4
8
*
C01CA24
ATC
epinephrine; parenteral
4.4
8.3
29
70
L50.9
ICD-10 Finland
Urticaria, unspecified
8.4
8.2
17
21
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.5
7.9
27
64
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
7.9
107
609
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.1
7.8
102
572
XW000
NOMESCO Finland
Bone marrow biopsy
5.0
7.8
24
51
JN4BD
NOMESCO Finland
Extensive body CT
2.7
7.8
53
215
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
7.8
68
315
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.3
7.7
81
410
S01GX01
ATC
cromoglicic acid; ophthalmic
2.4
7.6
67
309
D07AC03
ATC
desoximetasone; topical
9.2
7.6
15
17
XQ848
NOMESCO Finland
Dermatological photography
7.1
7.4
17
25
6929X
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]
+∞
7.3
7
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
7.3
103
592
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
30.7
7.2
9
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.7
7.1
48
192
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
7.1
57
253
R06AX13
ATC
loratadine; oral
2.5
7.0
57
255
RS224
NOMESCO Finland
NA
40.8
6.8
8
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
6.5
56
259
L04AC05
ATC
ustekinumab; parenteral
71.0
6.4
7
*
L21.0
ICD-10 Finland
Seborrhoea capitis
71.0
6.4
7
*
L08.0
ICD-10 Finland
Pyoderma
14.6
6.4
10
7
L04AB04
ATC
adalimumab; parenteral
8.4
6.4
13
16
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
6.4
47
199
S91
ICPC
Psoriasis
11.3
6.3
11
10
S21
ICPC
Skin texture symptom/complaint
2.6
6.3
47
200
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
18.4
6.3
9
5
WW409
NOMESCO Finland
Other aferesis
+∞
6.3
6
*
ZX196
NOMESCO Finland
NA
+∞
6.3
6
*
6929B
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]
+∞
6.3
6
*
1XX25
NOMESCO Finland
NA
+∞
6.3
6
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
6.2
30
98
N06AA12
ATC
doxepin; systemic
3.4
6.0
27
83
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
98
128
9.91
74.07
2.1
1.2
u/ml
3490.9
187.4
4.95
93
112
(40768443) Skin Pathology biopsy report
88
102
10.87
72.75
2.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
16
21.71
42.01
2.2
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
36
24
16.44
41.33
2.9
2.0
e9/l
1.5
1.0
0.56
24
11
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
33
19
18.89
40.69
2.2
1.7
%
10.3
13.3
—
22
7
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
25
18
14.78
27.31
3.2
2.1
e6/l
425.3
329.6
0.44
16
12
(42870588) Differential panel, method unspecified - Blood
197
972
3.09
26.36
13.1
5.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
250
1414
3.17
26.14
13.4
5.9
e9/l
0.7
0.6
4.20
234
1218
(3013115) Eosinophils [#/volume] in Blood
256
1468
3.20
26.12
13.5
6.0
e9/l
0.3
0.2
8.15
240
1289
(3006315) Basophils [#/volume] in Blood
250
1421
3.14
25.78
13.4
5.9
e9/l
0.0
0.0
2.20
236
1229
(3019198) Lymphocytes [#/volume] in Blood
250
1445
3.06
24.56
13.6
6.0
e9/l
2.0
1.9
0.12
239
1283
(3006504) Eosinophils/100 leukocytes in Blood
236
1336
2.96
23.83
14.0
6.0
%
4.2
2.8
6.98
231
1242
(3004588) Protein electrophoresis panel - Serum or Plasma
70
191
4.25
23.58
1.8
2.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
270
1655
3.09
23.36
18.0
9.1
e9/l
4.5
4.2
1.41
252
1441
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
92
309
3.59
23.02
5.7
3.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
236
1375
2.84
21.90
14.4
6.1
%
24.0
26.5
3.00
230
1278
(3018010) Neutrophils/100 leukocytes in Blood
233
1351
2.82
21.78
13.7
5.9
%
58.9
58.2
0.36
228
1266
(3007853) Bacteria identified in Skin by Aerobe culture
94
344
3.29
20.35
2.2
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
92
351
3.13
18.43
3.2
3.0
%
1.7
1.8
0.58
85
317
(3037522) Nuclear Ab [Titer] in Serum
87
330
3.11
17.54
1.6
1.3
titre
940.0
447.3
0.63
14
66
(3020630) Protein [Mass/volume] in Serum or Plasma
71
242
3.37
17.06
1.8
3.2
g/l
66.9
65.8
0.63
64
216
(3017181) Myelocytes/100 leukocytes in Blood
72
248
3.34
17.00
5.1
4.2
%
0.7
0.8
0.18
28
80
(3023520) Reticulocytes [#/volume] in Blood
71
250
3.25
16.14
3.3
3.2
e9/l
66.4
68.2
0.19
61
195
(3002179) Metamyelocytes/100 leukocytes in Blood
65
219
3.37
15.85
5.0
4.2
%
0.4
0.4
0.12
23
62
(3021440) Promyelocytes/100 leukocytes in Blood
67
232
3.28
15.63
5.1
4.3
%
0.1
0.1
0.05
25
73
(40760892) CBC W Ordered Manual Differential panel - Blood
125
615
2.53
15.09
9.4
5.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
21
28
7.87
14.97
1.0
1.0
u/ml
14.0
2.9
—
11
5
(3000060) B lymphocytes [#/volume] in Blood
19
6
33.18
14.94
2.1
1.3
e6/l
175.6
—
—
9
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
29
55
5.62
14.90
4.0
3.3
%
62.4
57.5
0.99
29
55
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
52
5.73
14.70
3.9
3.1
e9/l
4.8
4.4
0.43
28
52
(3025159) Blasts/100 leukocytes in Blood
64
226
3.19
14.41
4.6
4.3
%
0.0
0.2
0.43
21
67
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
23
36
6.73
14.26
1.1
1.1
u/ml
9.2
1.4
1.08
17
16
(3000093) Morphology [Interpretation] in Blood Narrative
17
20
8.84
13.34
1.6
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
18
9
20.89
12.57
1.8
1.0
ug/l
11.2
7.7
—
18
9
(3023368) Bacteria identified in Blood by Culture
156
911
2.19
12.21
6.6
4.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
106
528
2.39
12.12
1.7
1.4
g/l
2.9
2.6
0.59
68
320
(3012095) Magnesium [Moles/volume] in Serum or Plasma
100
494
2.38
11.59
4.5
3.9
mmol/l
0.8
0.8
2.82
91
464
(3003458) Phosphate [Moles/volume] in Serum or Plasma
86
401
2.47
11.30
9.0
6.3
mmol/l
1.1
1.0
0.65
80
368
(21494814) CD8 cells/100 lymphocytes in Specimen
12
11
11.23
11.11
2.3
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
15
22
7.05
9.80
1.1
1.0
u/ml
22.8
1.5
—
8
8
(3021589) Normoblasts [#/volume] in Blood
192
1288
1.97
9.74
21.1
9.8
e9/l
0.0
0.0
0.05
169
1057
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
127
736
2.08
9.73
2.6
2.0
mg/l
2.9
3.2
0.74
109
626
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
109
3.43
9.56
1.5
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
109
3.43
9.56
1.5
2.5
g/l
7.3
7.3
0.00
23
79
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
109
3.43
9.56
1.5
2.5
g/l
4.0
3.8
0.47
22
76
(3026782) Osmolality of Urine
111
621
2.10
9.28
3.0
3.2
mosm/kgh2o
576.6
588.2
0.21
101
530
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
31
92
3.58
9.11
1.5
2.9
g/l
0.8
1.0
0.09
25
79
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
99
3.43
8.83
1.5
2.6
g/l
3.4
3.2
0.24
22
77
(3028026) IgM [Mass/volume] in Serum or Plasma
48
192
2.71
8.54
1.6
1.8
g/l
0.8
1.8
1.97
42
176
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
285
2243
2.03
8.53
11.8
8.0
u/l
84.8
79.0
1.05
275
2089
(3013707) Erythrocyte sedimentation rate by Westergren method
271
2105
1.96
8.31
5.7
3.9
mm/h
15.4
12.5
1.85
264
1915
(3005719) IgG [Mass/volume] in Serum or Plasma
53
226
2.56
8.30
3.6
2.7
g/l
10.8
10.4
0.23
48
207
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
99
3.32
8.15
1.5
2.6
g/l
10.1
10.6
0.38
25
85
(46235355) HIV 1 and 2 tests - Meaningful Use set
85
452
2.13
8.00
1.7
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
117
700
1.96
7.96
13.2
7.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
181
1254
1.83
7.78
7.0
5.2
g/l
34.3
35.2
1.19
167
1170
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
8
15.42
7.76
2.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
49
209
2.54
7.66
1.6
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
79
418
2.12
7.50
3.1
2.7
%
25.5
23.0
0.63
74
368
(3000850) Epithelial cells [#/volume] in Urine
109
649
1.95
7.46
3.0
2.7
e6/l
4.3
4.0
0.13
98
564
(3001122) Ferritin [Mass/volume] in Serum or Plasma
168
1150
1.81
7.42
3.5
2.8
ug/l
206.3
172.2
0.57
155
1046
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
164
1129
1.79
7.00
4.1
3.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
27
89
3.19
6.76
1.6
2.7
g/l
37.3
37.4
0.04
22
73
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
94
557
1.91
6.43
1.4
1.2
u/ml
4.9
1.3
0.86
28
154
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
206
1543
1.72
6.33
8.6
6.9
umol/l
10.4
12.1
2.67
198
1463
(3017143) Hepatitis C virus Ab [Presence] in Serum
62
321
2.11
6.18
2.0
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
167
1188
1.71
6.15
2.3
2.0
pmol/l
86.4
95.0
2.22
121
628
(3032080) INR in Blood by Coagulation assay
174
1256
1.70
6.04
12.5
9.3
inr
1.2
1.3
0.37
52
377
(3003327) Ova and parasites identified in Stool by Light microscopy
20
59
3.52
5.94
1.4
1.8
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
10
9
11.37
5.82
1.2
1.6
umol/l
11.3
20.0
—
10
9
(3002582) Erythrocytes [#/volume] in Urine
139
954
1.71
5.75
3.8
3.4
e6/l
49.4
141.5
0.71
116
740
(3000494) Fungus identified in Specimen by Culture
62
331
2.04
5.68
1.8
1.5
—
—
—
0
0
(4035726)
50
248
2.17
5.55
1.7
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
44
208
2.26
5.48
2.2
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
73
3.14
5.46
1.2
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
137
950
1.68
5.39
4.3
3.5
mmol/l
2.3
2.3
0.13
117
827
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
30
4.45
5.33
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
40
3.86
5.14
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
76
3.01
5.12
2.8
5.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
82
2.92
5.07
1.2
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
92
580
1.77
5.06
2.0
1.7
nmol/l
1196.5
1200.4
0.01
72
442
(3026389) Candida sp identified in Specimen by Organism specific culture
11
23
4.89
5.04
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
112
748
1.70
5.01
3.7
2.9
umol/l
380.1
9270.9
3.90
98
646
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
129
899
1.65
4.90
2.1
2.1
u/l
337.8
281.0
0.16
123
843
(3021960) Folate [Moles/volume] in Serum or Plasma
105
694
1.70
4.87
1.9
1.5
nmol/l
20.2
20.0
0.04
94
585
(3018418) pH of Serum or Plasma
123
849
1.66
4.84
6.1
4.4
ph
7.4
7.4
0.22
34
166
(3018095) Leukocytes [#/volume] in Urine
149
1080
1.62
4.82
4.4
4.0
e6/l
76.8
133.8
0.39
120
786
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
52
3.37
4.80
1.9
2.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
33
146
2.38
4.79
1.5
2.3
g/l
1.6
1.5
0.30
26
129
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
66
383
1.87
4.74
1.8
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
119
819
1.65
4.72
3.6
3.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
148
1078
1.60
4.66
2.7
2.3
nmol/l
71.8
77.0
1.59
139
946
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
81
2.82
4.59
2.2
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
59
3.15
4.57
2.3
2.9
%
16.2
16.0
—
9
35
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
187
1448
1.56
4.48
9.8
7.1
mmol/l
1.2
1.2
0.24
145
1208
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
6
11.85
4.29
1.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
220
1778
1.55
4.28
6.3
4.9
mmol/l
7.0
6.8
0.51
211
1669
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
36
3.70
4.24
3.8
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
122
865
1.60
4.22
3.7
3.3
e6/l
0.4
0.6
0.71
104
655
(3037756) Immunofixation for Serum or Plasma
19
69
2.84
4.08
1.7
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
38
3.51
3.93
2.1
3.0
pg
34.6
33.4
0.63
13
38
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
24
101
2.47
3.90
2.9
4.5
mg/l
30.7
34.7
0.35
17
81
(3034860) Kappa light chains.free [Mass/volume] in Serum
24
101
2.47
3.90
2.9
4.5
mg/l
66.8
134.7
0.48
17
80
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
77
2.68
3.87
3.1
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
47
262
1.90
3.81
4.3
3.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
39
3.41
3.79
6.4
4.1
—
—
—
0
0
(3000492) Spirometry study
47
264
1.89
3.73
1.5
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
56
2.94
3.67
1.3
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
51
3.02
3.61
1.9
1.7
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
10
26
3.92
3.54
1.2
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
26
3.92
3.54
1.6
3.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
168
1319
1.48
3.52
8.9
6.3
mmol/l
1.2
1.2
0.19
156
1174
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
56
343
1.74
3.36
2.2
1.8
%
2.1
1.6
2.79
51
298
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
236
1998
1.46
3.27
5.5
3.5
pmol/l
14.7
14.9
0.58
220
1762
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
62
394
1.68
3.26
1.4
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
28
3.64
3.21
1.3
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
33
3.40
3.21
1.5
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
124
932
1.49
3.16
3.9
4.1
mg/mmol
6.9
10.0
0.73
83
624
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
87
2.37
3.06
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
51
2.81
3.02
1.4
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
51
2.81
3.02
1.4
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
69
461
1.60
2.99
2.6
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
74
503
1.58
2.98
2.5
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
48
293
1.73
2.92
5.5
4.6
mmol/l
1.8
1.7
0.09
38
227
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
30
3.40
2.92
1.7
1.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
44
262
1.77
2.92
2.4
2.2
u/l
53.0
219.9
0.43
36
219
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
123
936
1.46
2.91
2.5
2.5
u/l
49.7
55.8
1.87
116
870
(3032773) Endomysium IgG Ab [Titer] in Serum
9
22
4.16
2.90
1.3
1.0
—
—
—
0
0
(3012544) pH of Venous blood
49
302
1.71
2.89
5.4
4.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
116
875
1.47
2.87
3.0
3.3
mg/l
1563.2
203.1
0.88
79
600
(36660697) Celiac disease serology panel - Serum
33
181
1.90
2.84
1.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
55
354
1.65
2.76
3.0
3.3
umol/l
5.1
9.4
3.71
50
320
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
60
2.56
2.73
3.3
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
36
206
1.82
2.73
5.0
4.0
mmol/l
1.2
1.8
0.31
30
152
(3035637) Corticotropin [Mass/volume] in Plasma
9
24
3.81
2.69
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
149
1.95
2.64
1.5
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
7
15
4.73
2.61
1.6
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
120
929
1.42
2.55
3.1
3.2
mmol/l
7.5
8.1
0.69
101
773
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
82
2.25
2.51
3.3
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
82
2.25
2.51
3.6
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
39
2.87
2.49
1.7
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
89
2.19
2.49
5.4
3.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
16
4.43
2.48
9.9
13.0
nmol/l
765.7
915.9
—
7
16
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
16
4.43
2.48
13.0
15.2
nmol/l
1079.7
1553.6
—
7
16
(3003694) ABO and Rh group [Type] in Blood
102
770
1.44
2.48
1.5
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
70
2.34
2.44
4.2
2.9
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
12
5.06
2.41
6.0
2.9
%
101.2
95.1
—
6
12
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
75
536
1.50
2.40
4.6
3.2
mmol/l
2.4
2.4
0.18
62
468
(3021788) Differential panel - Synovial fluid
12
46
2.66
2.38
1.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
59
2.42
2.32
1.2
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
107
825
1.41
2.30
3.8
3.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
47
2.60
2.29
1.8
3.5
—
—
—
0
0
(3009343) pH of Capillary blood
36
218
1.72
2.28
5.1
3.9
ph
7.4
7.4
—
5
21
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
18
3.94
2.26
1.7
2.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
84
622
1.45
2.25
1.9
1.8
pmol/l
380.3
431.6
0.81
72
519
(3000991) Gas panel - Venous blood
42
267
1.64
2.23
10.1
9.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
84
625
1.44
2.19
2.2
1.7
mg/l
1.9
1.5
0.40
62
494
(3037467) Urinalysis macro (dipstick) panel - Urine
227
1986
1.35
2.16
6.2
4.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
167
1396
1.35
2.16
6.1
5.0
estimate
0.0
0.0
0.00
51
275
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
30
3.05
2.16
1.2
1.2
—
68.0
—
0
5
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
19
3.73
2.16
1.7
2.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
14
4.34
2.16
1.0
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
14
4.34
2.16
1.0
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
169
1417
1.34
2.14
4.5
3.6
estimate
0.0
0.0
0.00
48
262
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
218
1898
1.34
2.13
4.4
3.2
u/l
74.8
53.0
1.27
210
1766
(3029937) Albumin [Presence] in Urine by Test strip
102
791
1.39
2.11
4.3
3.7
estimate
0.0
0.0
0.50
46
267
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
25
3.25
2.10
1.8
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
110
1.96
2.10
3.8
2.7
u/ml
0.4
0.3
0.31
13
65
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
31
2.95
2.08
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
167
1404
1.33
2.05
4.5
3.6
estimate
0.0
0.0
0.00
49
273
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
15
4.05
2.04
1.3
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
50
2.44
2.04
1.6
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
51
348
1.54
2.03
2.0
1.9
—
—
—
0
0
(44813793)
5
11
4.59
1.94
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
27
3.00
1.94
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
52
2.35
1.89
1.3
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
405
1.48
1.89
1.4
1.3
u/ml
4.7
14.1
1.48
22
161
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
22
3.22
1.89
1.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
50
346
1.51
1.88
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
79
2.07
1.88
1.1
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
79
2.07
1.88
1.1
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
99
778
1.37
1.87
4.5
3.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
12
4.21
1.83
1.4
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
12
4.21
1.83
1.8
5.8
%
57.9
50.8
—
5
12
(42529406) Shigella sp [Presence] in Stool by Culture
16
80
2.04
1.82
1.1
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
74
2.07
1.77
2.4
2.3
g/l
135.4
131.2
—
10
52
(3010421) pH of Blood
16
81
2.02
1.77
5.3
3.1
ph
7.4
7.4
0.02
16
64
(3022313) Gas panel - Capillary blood
27
164
1.69
1.73
6.0
3.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
48
2.33
1.72
5.4
3.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
13
3.88
1.72
2.4
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
55
2.22
1.69
1.9
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
42
2.42
1.69
1.4
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
83
1.97
1.67
1.2
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
23
135
1.75
1.66
6.7
4.5
mmol/l
24.9
24.9
0.01
23
125
(3013512) EKG study
108
876
1.32
1.65
4.3
4.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
14
3.60
1.62
1.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
14
3.60
1.62
1.0
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
121
1.78
1.62
4.1
3.6
g/l
0.3
0.3
0.02
13
55
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
63
2.10
1.61
1.3
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
74
569
1.37
1.60
3.4
3.9
ng/l
902.5
423.4
0.54
62
465
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
49
350
1.46
1.60
1.9
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
115
948
1.30
1.56
4.1
2.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
33
2.45
1.54
1.4
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
44
2.31
1.54
1.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
15
3.36
1.53
1.2
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
15
3.36
1.53
1.6
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
27
2.62
1.52
1.3
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
58
2.10
1.50
1.4
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
132
1114
1.28
1.49
4.6
3.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
7
28
2.53
1.46
1.4
1.4
mu/l
113.9
36.3
—
7
23
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
141
1.67
1.45
1.1
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
59
2.07
1.45
1.9
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
16
3.15
1.44
1.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
16
3.15
1.44
1.0
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
68
525
1.36
1.44
3.1
3.0
e6/l
0.9
1.0
0.07
43
310
(40761535) Cells panel - Urine sediment
36
247
1.50
1.44
4.8
3.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
18
103
1.78
1.43
1.1
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
190
1.57
1.42
1.5
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
40
2.28
1.41
1.2
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
162
0.48
1.39
1.6
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
88
710
1.31
1.39
4.4
2.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
37
0.00
1.35
0.0
1.2
—
7.8
—
0
26
(3000475) Leukocytes [#/volume] in Synovial fluid
13
68
1.94
1.35
1.5
1.5
e6/l
28254.7
12725.5
—
6
51
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
308
2898
1.31
1.33
27.2
15.3
mg/l
25.1
25.9
0.18
280
2310
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
115
967
1.27
1.32
3.3
3.3
ng/l
3143.2
1639.8
0.58
108
836
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
44
2.07
1.27
1.6
1.2
—
56.5
—
0
5
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
25
2.42
1.25
1.2
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
63
1.93
1.24
2.0
2.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
49
2.07
1.23
2.1
1.8
—
—
—
0
0
(44790047)
8
37
2.19
1.22
2.0
1.6
—
—
—
0
0
(44806118)
8
37
2.19
1.22
2.0
1.6
—
—
—
0
0
(44790048)
8
37
2.19
1.22
2.0
1.6
—
—
—
0
0
(44790049)
8
37
2.19
1.22
2.0
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
19
2.65
1.22
2.4
3.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
224
0.57
1.21
1.8
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
117
1.66
1.20
2.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
125
1.63
1.20
3.5
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
12
64
1.90
1.19
1.8
1.5
miu/ml
230.8
242.6
—
5
32
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
38
2.13
1.19
1.6
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
29
200
1.49
1.16
1.9
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
39
2.07
1.16
1.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
39
2.07
1.16
1.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
39
2.07
1.16
1.6
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
5
20
2.52
1.15
2.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
5
114
0.43
1.14
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
40
2.02
1.12
1.6
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
40
2.02
1.12
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
40
2.02
1.12
1.3
1.3
nmol/l
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
72
877
0.78
1.11
2.9
3.1
ug/l
0.5
0.8
6.24
55
574
(3027273) Bicarbonate [Moles/volume] in Venous blood
24
161
1.52
1.09
3.8
3.7
mmol/l
23.9
24.8
0.52
24
155
(3036603) Volume of Urine
5
21
2.40
1.09
1.0
1.6
—
1552.2
—
0
5
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
64
513
1.30
1.07
3.5
3.2
e6/l
1.4
1.5
0.14
38
301
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
54
423
1.32
1.06
1.4
1.2
iu/ml
25.4
39.8
0.64
22
133
(3020891) Body temperature
19
122
1.59
1.04
9.1
4.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
75
1.76
1.04
1.5
1.3
—
—
—
0
0
(4062490)
5
22
2.29
1.03
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
47
1.94
1.03
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
131
1.56
1.02
1.1
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
35
2.02
1.00
1.0
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
108
1.60
0.98
2.8
3.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
54
1.87
0.97
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
50
1.82
0.97
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
139
1230
1.20
0.96
4.5
3.9
ng/l
47.8
42.7
0.11
103
911
(1761482) Bacteria [#/volume] in Urine by Culture
16
101
1.61
0.95
5.1
5.2
—
—
—
0
0
(4010399)
28
201
1.42
0.94
1.7
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
269
2531
1.21
0.93
6.0
4.2
mu/l
1.9
2.4
0.60
253
2260
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
36
274
1.35
0.88
2.2
2.8
ug/l
9.3
8.1
0.15
31
251
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
73
1.66
0.82
1.5
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
303
0.71
0.80
2.0
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
33
1.83
0.79
2.3
4.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
150
1357
1.17
0.79
6.3
4.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
34
1.78
0.76
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
106
1194
0.85
0.75
3.6
4.3
%
16.7
21.6
2.51
48
583
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
38
1.86
0.74
4.7
3.9
umol/l
363.7
316.4
—
7
32
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
137
1508
0.86
0.73
4.5
5.0
ug/l
3.9
2.9
0.25
119
1329
(3019832) Treponema pallidum Ab [Presence] in Serum
26
195
1.36
0.71
1.6
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
27
204
1.35
0.71
3.5
3.5
g/l
128.9
128.8
0.00
27
199
(40768795) Lymph node Pathology biopsy report
5
26
1.93
0.71
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
5.1
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
42
1.68
0.68
1.7
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
42
1.68
0.68
2.1
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
237
0.70
0.68
1.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(4268621)
5
29
1.73
0.64
1.8
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
22
164
1.36
0.64
4.5
4.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
267
0.74
0.63
2.7
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
30
1.68
0.61
8.4
2.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
277
2880
0.87
0.61
5.9
4.9
mmol/l
2.6
2.7
1.36
257
2633
(4024509)
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
113
0.61
0.59
3.0
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
38
311
1.25
0.58
2.1
2.0
nmol/l
13.8
13.5
0.07
38
274
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
284
2731
1.15
0.57
25.8
14.3
ml/min/173m2
79.9
78.9
0.30
257
2273
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
5.7
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
38
314
1.23
0.54
2.4
2.4
ug/g
177.5
137.9
0.35
31
255
(3003396) Base excess in Arterial blood by calculation
45
382
1.20
0.50
9.2
7.3
mmol/l
1.1
1.2
0.02
34
292
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
233
0.76
0.48
1.9
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
32
383
0.82
0.46
4.0
4.7
%
30.0
31.5
0.23
23
256
(3009542) Hematocrit [Volume Fraction] of Blood
269
2595
1.12
0.45
27.3
16.2
%
39.1
40.0
0.73
179
1809
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
80
722
1.14
0.43
2.0
1.6
mmol/l
1.5
1.4
0.28
67
589
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
31
1.62
0.43
1.4
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
91
0.65
0.43
1.3
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
57
1.41
0.42
2.0
2.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.0
1.2
—
73.7
—
0
8
(3040151) Glucose [Moles/volume] in Capillary blood
5
36
1.39
0.38
6.2
9.6
mmol/l
7.3
7.0
—
5
30
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
235
0.80
0.38
2.7
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
212
0.79
0.36
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
71
1.27
0.36
2.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
272
2796
0.91
0.35
5.5
4.5
mmol/l
1.3
1.4
1.15
252
2556
(3045424) Erythrocytes [Presence] in Urine
6
47
1.28
0.32
1.5
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
83
1.33
0.32
2.3
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
221
1.19
0.31
4.3
3.4
ml/min/173m2
61.9
64.3
—
10
92
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
325
1.15
0.31
2.5
4.9
ug/l
4.9
52.5
1.20
30
275
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
84
1.32
0.30
1.5
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
56
1.25
0.29
1.4
2.8
%
64.9
63.6
—
7
56
(3049717) Cytology report of Urine Cyto stain
17
139
1.23
0.29
2.2
3.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
85
1.30
0.28
2.3
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
62
1.30
0.28
3.6
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
63
1.28
0.28
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
162
1685
0.93
0.25
3.0
2.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
103
1088
0.93
0.24
2.6
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
87
1.27
0.24
2.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
87
1.27
0.24
2.4
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
38
1.32
0.23
1.4
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
47
430
1.11
0.22
24.2
26.7
inr
1.3
1.2
—
10
45
(3012441) Differential panel - Pleural fluid
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
10
0.00
0.21
0.0
1.2
—
3.1
—
0
10
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4034850)
8
102
0.78
0.21
11.0
10.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.6
—
5944.5
—
0
6
(3019060) Gas panel - Arterial blood
25
221
1.14
0.20
7.2
4.6
—
—
—
0
0
(3002256) Pathology report gross observation
40
365
1.11
0.20
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
276
2810
0.94
0.20
6.6
4.5
mmol/l
4.4
4.5
0.96
258
2586
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
14
0.00
0.20
0.0
1.2
—
7.6
—
0
14
(3045414) Leukocytes [Presence] in Urine
14
118
1.19
0.19
1.7
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
305
3006
1.07
0.18
28.7
17.9
mmol/l
4.0
4.0
0.85
299
2926
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
60
1.17
0.18
2.1
1.1
u/l
36.7
53.9
—
7
50
(3024928) Oxygen saturation in Venous blood
8
69
1.16
0.16
2.1
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
210
2056
1.05
0.15
4.4
4.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
261
2649
0.95
0.14
6.5
6.1
mmol/mol
40.1
40.7
0.42
242
2443
(40761511) CBC panel - Blood by Automated count
299
3025
0.95
0.14
25.1
14.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
356
0.92
0.14
13.5
7.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
303
2998
1.05
0.12
28.7
17.8
mmol/l
139.0
139.7
4.69
298
2921
(40768800) Prostate Pathology biopsy report
11
95
1.16
0.11
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
96
992
0.96
0.11
4.1
2.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
86
1.17
0.11
2.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
86
1.17
0.11
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
30
281
1.07
0.10
7.3
4.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
45
1.11
0.10
1.2
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.3
e6/l
109.0
15.1
—
5
41
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.3
e6/l
8.6
176.9
—
5
41
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
174
1.10
0.09
10.7
9.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
6
54
1.11
0.09
1.5
1.4
g/l
31.3
31.5
—
6
45
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
55
1.09
0.09
1.5
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
61
0.82
0.08
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
63
0.79
0.08
2.0
2.2
—
—
—
0
0
(4094501)
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
85
0.82
0.07
2.7
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
18
193
0.93
0.06
2.4
2.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
31
325
0.95
0.06
1.5
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
66
645
1.03
0.04
4.2
3.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
133
1.05
0.01
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
153
1.05
0.01
2.6
2.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
273
2722
1.01
0.01
6.3
4.0
mmol/l
1.4
1.3
2.38
254
2475
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
144
1.04
0.00
1.5
1.3
—
28.8
—
0
11
(3017732) Neutrophils [#/volume] in Blood
19
184
1.03
0.00
2.8
2.7
e9/l
5.6
4.0
1.11
13
139
(3019150) Specific gravity of Urine by Refractometry
64
646
0.99
0.00
4.9
3.6
kg/l
1.0
1.0
—
9
90
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
279
2786
1.01
0.00
5.2
4.6
mmol/l
6.1
6.0
0.16
262
2522
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.4
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
57
0.88
0.00
1.2
1.4
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
9.1
—
0
5
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
69.4
—
0
5
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
7
0.00
0.00
0.0
3.0
—
12.6
—
0
7
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
22.2
—
0
5
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
6.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
49
1.02
0.00
1.6
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
16.7
—
0
5
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
21.9
—
0
7
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
4.2
—
12391.3
—
0
6
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
91
0.99
0.00
1.2
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
42.2
—
0
5
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_EXFOLIATIVE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_EXFOLIATIVE | 2.068 [1.66, 2.57] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.049 |
During the follow-up period (1.1.1998 — 31.12.2019), 324 out of 966 females with L12_EXFOLIATIVE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_EXFOLIATIVE | 2.357 [1.97, 2.82] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 723 out of 1728 males with L12_EXFOLIATIVE died.
Mortality risk
Mortality risk for people of age
years, who have L12_EXFOLIATIVE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.14% | 0.419% |
| 5 | 1.185% | 2.546% |
| 10 | 2.717% | 6.481% |
| 15 | 5.238% | 11.839% |
| 20 | 9.028% | 19.972% |
Relationships between endpoints
↥Index endpoint: L12_EXFOLIATIVE – Exfoliative dermatitis
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data